The How And When Of Applying Sequencing To Clinical Diagnostics
By
Mark Ratner / Email the Author / IN VIVO September 2010, Vol. 28, No. 8
Feature Articles / Word Count: 4750 / Article # 2010800138
Executive Summary
Gene sequencing instrument providers are currently at the center of a range of corporate activities: acquisition, partnering, financing. As technology innovation continues, costs decrease, and the pace and scope of clinical genomic studies picks up, the notion of sequencing as the foundation for a clinical diagnostics platform is gaining more support. Delivering value to diagnostics customers ultimately may demand that instrument providers move downstream, involving themselves in data analysis and workflow and even test development, to prime the clinical market.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.